Renaud, S.; Lefebvre, A.; Mordon, S.; Moralès, O.; Delhem, N.
Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma. Int. J. Mol. Sci. 2020, 21, 4292.
https://doi.org/10.3390/ijms21124292
AMA Style
Renaud S, Lefebvre A, Mordon S, Moralès O, Delhem N.
Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma. International Journal of Molecular Sciences. 2020; 21(12):4292.
https://doi.org/10.3390/ijms21124292
Chicago/Turabian Style
Renaud, Sarah, Anthony Lefebvre, Serge Mordon, Olivier Moralès, and Nadira Delhem.
2020. "Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma" International Journal of Molecular Sciences 21, no. 12: 4292.
https://doi.org/10.3390/ijms21124292
APA Style
Renaud, S., Lefebvre, A., Mordon, S., Moralès, O., & Delhem, N.
(2020). Novel Therapies Boosting T Cell Immunity in Epstein Barr Virus-Associated Nasopharyngeal Carcinoma. International Journal of Molecular Sciences, 21(12), 4292.
https://doi.org/10.3390/ijms21124292